Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression
Clinical trial NCT05661357 · UNKNOWN
Trial details
- NCT number
- NCT05661357
- Sponsor
- Zhongnan Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2025-01-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.